drugset / Trial / NCT02159976
Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Completed
390 enrolled
Seoul National University Bundang Hospital
Chong Kun Dang Pharmaceutical · collabGreen Cross Corporation · collabHK inno.N Corporation · collabSK Chemicals Co., Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
1. To compare 10-day sequential therapy and 14-day modified bismuth quadruple therapy and to establish more effective first-line regimen for the eradication of Helicobacter pylori in Korea. 2. To evaluate the effect of H. pylori eradication therapy on the symptom improvement of functional dyspepsia
Timeline
- Start
- 2014-07
- Primary completion
- 2015-05
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Bismuth Potassium Citrate | Unknown | 600 mg | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Comparator | Metronidazole | Small molecule | 500 mg | — |
| Subject | Pantoprazole | Other / unclassified | 40 mg | — |
| Subject | Tetracycline | Unknown | 1000 mg | — |